On the public citation graph
Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study
0 signed · 66 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.20734openalex-snapshot
Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #
inferredcites →https://doi.org/10.1002/hep.24452openalex-snapshot
Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
inferredcites →https://doi.org/10.1002/hep.28431openalex-snapshot
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
inferredcites →https://doi.org/10.1002/hep.29302openalex-snapshot
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis
inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/sim.1203openalex-snapshot
Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects
inferredcites →https://doi.org/10.1007/bf00280883openalex-snapshot
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
inferredcites →https://doi.org/10.1007/s12020-020-02268-7openalex-snapshot
Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor
inferredcites →https://doi.org/10.1016/j.amjmed.2010.08.012openalex-snapshot
Hyperinsulinemia and the Development of Nonalcoholic Fatty Liver Disease in Nondiabetic Adults
inferredcites →https://doi.org/10.1016/j.cgh.2018.07.006openalex-snapshot
Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1016/j.cmet.2015.04.004openalex-snapshot
Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
inferredcites →https://doi.org/10.1016/j.jhep.2010.04.030openalex-snapshot
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
inferredcites →https://doi.org/10.1016/j.jhep.2013.04.027openalex-snapshot
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
inferredcites →https://doi.org/10.1016/j.jhep.2014.11.034openalex-snapshot
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
inferredcites →https://doi.org/10.1016/j.jhep.2015.11.004openalex-snapshot
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s1590-8658(02)80111-6openalex-snapshot
Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases
inferredcites →https://doi.org/10.1038/ajg.2009.587openalex-snapshot
Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and Hypertension
inferredcites →https://doi.org/10.1038/nrdp.2015.80openalex-snapshot
Nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1038/nrgastro.2013.41openalex-snapshot
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
inferredcites →https://doi.org/10.1053/jhep.2003.50161openalex-snapshot
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
inferredcites →https://doi.org/10.1053/jhep.2003.50346openalex-snapshot
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
inferredcites →https://doi.org/10.1055/s-0035-1550065openalex-snapshot
Fibrosis in Nonalcoholic Fatty Liver Disease: Mechanisms and Clinical Implications
inferredcites →https://doi.org/10.1093/ajcn/80.1.217openalex-snapshot
Alcohol consumption and the metabolic syndrome in Korean adults: the 1998 Korean National Health and Nutrition Examination Survey
inferredcites →https://doi.org/10.1111/apt.14401openalex-snapshot
Systematic review with meta‐analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1365-2036.2011.04724.xopenalex-snapshot
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
inferredcites →https://doi.org/10.1111/jgh.14595openalex-snapshot
HOMA‐IR : An independent predictor of advanced liver fibrosis in nondiabetic non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/liv.13643openalex-snapshot
Global epidemiology of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: What we need in the future
inferredcites →https://doi.org/10.1136/gut.2010.216077openalex-snapshot
Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1136/gutjnl-2017-313884openalex-snapshot
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
inferredcites →https://doi.org/10.1148/rg.266065004openalex-snapshot
Fatty Liver: Imaging Patterns and Pitfalls
inferredcites →https://doi.org/10.1177/0962280216680383openalex-snapshot
The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation
inferredcites →https://doi.org/10.1186/s12944-017-0572-9openalex-snapshot
A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1210/jc.2006-0587openalex-snapshot
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1371/journal.pone.0158710openalex-snapshot
Waist Gain Is Associated with a Higher Incidence of Nonalcoholic Fatty Liver Disease in Korean Adults: A Cohort Study
inferredcites →https://doi.org/10.17235/reed.2018.5118/2017openalex-snapshot
Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.2337/dc06-2247openalex-snapshot
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
inferredcites →https://doi.org/10.2337/dc21-s002openalex-snapshot
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
inferredcites →https://doi.org/10.2337/diacare.20.7.1087openalex-snapshot
The Homeostasis Model in the San Antonio Heart Study
inferredcites →https://doi.org/10.3390/jcm7080219openalex-snapshot
Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-Analysis
inferredcites →https://doi.org/10.3390/nu5051544openalex-snapshot
Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease
inferredcites →https://doi.org/10.3748/wjg.v20.i2.475openalex-snapshot
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.3803/enm.2020.35.1.165openalex-snapshot
Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
inferredcites →https://doi.org/10.4082/kjfm.2012.33.3.144openalex-snapshot
Validity and Reliability of Korean Version of International Physical Activity Questionnaire Short Form in the Elderly
inferredcites →https://doi.org/10.4254/wjh.v6.i5.274openalex-snapshot
Gender and racial differences in nonalcoholic fatty liver disease
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.72.e167064zenodo-depositor-declared
Association between intelectin-1, sleep quality, and insulin resistance in infertile women of reproductive age
inferred← citeshttps://doi.org/10.1002/lary.70009openalex-snapshot
Positive Airway Pressure Therapy for Obstructive Sleep Apnea in High‐Risk Pregnancy: A Meta‐Analysis
inferred← citeshttps://doi.org/10.1007/s10620-024-08309-9openalex-snapshot
Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis
inferred← citeshttps://doi.org/10.1016/j.jcjd.2023.06.002openalex-snapshot
Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.metop.2025.100402openalex-snapshot
Association between HOMA-IR and metabolic dysfunction-associated steatohepatitis in U.S. adults with MASLD
inferred← citeshttps://doi.org/10.1038/s41598-023-47269-4openalex-snapshot
Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
inferred← citeshttps://doi.org/10.1038/s41598-025-15425-7openalex-snapshot
HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patients
inferred← citeshttps://doi.org/10.1111/bjh.18492openalex-snapshot
The association between steatosis and liver damage in transfusion‐dependent beta thalassaemia patients
inferred← citeshttps://doi.org/10.21203/rs.3.rs-11285131/v1openalex-snapshot
Hepatic Insulin Resistance Syndrome (HIRS): A Proposed Framework for the Classification of Steatotic Liver Disease
inferred← citeshttps://doi.org/10.2147/ijgm.s395948openalex-snapshot
Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.2147/jir.s502314openalex-snapshot
Deciphering the Role of CD36 in Gestational Diabetes Mellitus: Linking Fatty Acid Metabolism and Inflammation in Disease Pathogenesis
inferred← citeshttps://doi.org/10.3389/fendo.2025.1514093openalex-snapshot
Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020
inferred← citeshttps://doi.org/10.3390/ijms26115057openalex-snapshot
Flexible Parametric Survival Modeling of Transaminases as Predictive Biomarkers for Non-Alcoholic Fatty Liver Disease: A Retrospective Longitudinal Study (2012–2022)
inferred← citeshttps://doi.org/10.3390/life16060939openalex-snapshot
Insulin Resistance as a Dynamic Correlate of Fibrosis Status in Chronic Hepatitis B: A Visit-Level Longitudinal Risk Stratification Framework
inferred← citeshttps://doi.org/10.3390/nu14153039openalex-snapshot
Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.36011/cpp.2022.4.e17openalex-snapshot
The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
inferred← citeshttps://doi.org/10.3803/enm.2021.1110openalex-snapshot
Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
inferred← citeshttps://doi.org/10.4093/dmj.2023.0350openalex-snapshot
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
inferred← citeshttps://doi.org/10.4103/mjbl.mjbl_903_23openalex-snapshot
Afamin Is a Novel Marker for Increasing Complications for Patients with Type 2 Diabetes Mellitus Obese
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.